ENLIVEN THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
ENLIVEN THERAPEUTICS, INC. (ELVN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 1.29 million shares as of 2022-12-31, per its 10-K filed 2023-02-10.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2023-02-10
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.29M shares.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.16M shares.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.27M shares.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.11M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2022-12-31 | 1.29M shares 10-K · filed 2023-02-10 |
| 2022-09-30 | 1.16M shares 10-Q · filed 2022-10-25 |
| 2022-06-30 | 1.27M shares 10-Q · filed 2022-08-03 |
| 2022-03-31 | 1.11M shares 10-Q · filed 2022-05-06 |
| 2021-12-31 | 880.96K shares 10-K · filed 2022-03-15 |
| 2021-09-30 | 764.73K shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 715.36K shares 10-Q · filed 2021-08-06 |
| 2021-03-31 | 701.35K shares 10-Q · filed 2021-05-11 |
| 2020-12-31 | 602.99K shares 10-K · filed 2021-03-05 |
| 2020-09-30 | 706.69K shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 691.24K shares 10-Q · filed 2020-08-14 |
| 2020-03-31 | 582.71K shares 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |